An integrated stress response via PKR suppresses HER2+ cancers and improves trastuzumab therapy

Bibliographic Details
Title: An integrated stress response via PKR suppresses HER2+ cancers and improves trastuzumab therapy
Authors: Cedric Darini, Nour Ghaddar, Catherine Chabot, Gloria Assaker, Siham Sabri, Shuo Wang, Jothilatha Krishnamoorthy, Marguerite Buchanan, Adriana Aguilar-Mahecha, Bassam Abdulkarim, Jean Deschenes, Jose Torres, Josie Ursini-Siegel, Mark Basik, Antonis E. Koromilas
Source: Nature Communications, Vol 10, Iss 1, Pp 1-14 (2019)
Publisher Information: Nature Portfolio, 2019.
Publication Year: 2019
Collection: LCC:Science
Subject Terms: Science
More Details: The HER2 monoclonal antibody, Trastuzumab, is the current standard treatment for HER2+ cancers but resistance to therapy occurs. Here, the authors show that activation of the PKR/eIF2α-P pathway exhibits anti-tumor effects in HER2+ cancer and is required for the response to Trastuzumab.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2041-1723
Relation: https://doaj.org/toc/2041-1723
DOI: 10.1038/s41467-019-10138-8
Access URL: https://doaj.org/article/7ecf6c59b1264893ab9910b75de10e72
Accession Number: edsdoj.7ecf6c59b1264893ab9910b75de10e72
Database: Directory of Open Access Journals
More Details
ISSN:20411723
DOI:10.1038/s41467-019-10138-8
Published in:Nature Communications
Language:English